Cargando…
Histone deacetylase signaling in cardioprotection
Cardiovascular disease (CVD) represents a major challenge for health care systems, both in terms of the high mortality associated with it and the huge economic burden of its treatment. Although CVD represents a diverse range of disorders, they share common compensatory changes in the heart at the st...
Autores principales: | Lehmann, Lorenz H., Worst, Barbara C., Stanmore, David A., Backs, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Basel
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983897/ https://www.ncbi.nlm.nih.gov/pubmed/24310814 http://dx.doi.org/10.1007/s00018-013-1516-9 |
Ejemplares similares
-
Class IIa histone deacetylases link cAMP signaling to the myelin transcriptional program of Schwann cells
por: Gomis-Coloma, Clara, et al.
Publicado: (2018) -
Histone Deacetylase Inhibitors: A Novel Strategy for Neuroprotection and Cardioprotection Following Ischemia/Reperfusion Injury
por: Pickell, Zachary, et al.
Publicado: (2020) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020) -
Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011) -
Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)